Global Clinical Trial Biorepository & Archiving Solutions Market Size Study, by Service (Biorepository Services, Archiving Solution Services), by Product, by Phase, and Regional Forecasts 2022-2032

Description

The Global Clinical Trial Biorepository & Archiving Solutions Market is valued at approximately USD 4.05 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.18% over the forecast period 2024-2032. Clinical trial biorepository and archiving solutions play a pivotal role in modern medical research by ensuring the secure storage and management of biological samples and critical trial data. These solutions facilitate advanced research by enabling scientists to access well-preserved materials for drug development, personalized medicine, and therapeutic advancements.

The market has witnessed a significant upsurge in demand, driven by the exponential growth in clinical trials globally and the increasing need for efficient biobanking solutions. Advanced archiving technologies are enabling researchers to retrieve and analyze biological specimens with unmatched precision, thus accelerating the pace of groundbreaking discoveries. Moreover, the integration of digital technologies such as blockchain and AI-driven analytics in biorepository services is reshaping the landscape, ensuring enhanced security and reliability of stored data and materials.

The industry is further boosted by robust investments in R&D and the growing prevalence of chronic and infectious diseases necessitating more comprehensive trial data management. Additionally, the expansion of pharmaceutical pipelines and the rise in multi-center trials have underscored the necessity for scalable biorepository infrastructures. Despite these growth enablers, challenges persist, including the high costs of maintaining advanced storage facilities and stringent regulatory requirements that may constrain market expansion.

Geographically, North America commands the largest share in the global clinical trial biorepository and archiving solutions market, bolstered by well-established healthcare infrastructure and the presence of leading market players. The region's commitment to research excellence and substantial funding initiatives foster an environment conducive to innovation. Europe follows closely, with significant advancements in biobanking technologies and supportive regulatory frameworks driving market growth. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market, attributed to the increasing number of clinical trials, burgeoning pharmaceutical industries, and rising investments in healthcare infrastructure.

Major market players included in this report are:

Advanced Solutions, Inc.
Medprin Biotech GmbH
3D Systems Corporation
Organovo Holdings, Inc.
Desktop Metal, Inc.
CollPlant Biotechnologies Ltd
Cyfuse Biomedical K.K
REGEMAT 3D S.L
Shining 3D
The Bio Convergence Company
Biostorage Technologies, Inc.
Hamilton Company
Brooks Life Sciences
Thermo Fisher Scientific
Tecan Group Ltd

The detailed segments and sub-segment of the market are explained below:

By Service:

Biorepository Services
Archiving Solution Services

By Product:

Instruments
Consumables

By Phase:

Preclinical
Phase I
Phase II
Phase III
Phase IV

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
ROE

Asia Pacific:

China
India
Japan
Australia
South Korea
RoAPAC

Latin America:

Brazil
Mexico

Middle East & Africa:

Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024 to 2032

Key Takeaways:

Market estimates & forecasts for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Comprehensive analysis of geographical landscape with country-level insights for major regions.
Competitive landscape profiling major market players.
Insights into key business strategies and recommendations for future market approaches.
Demand-side and supply-side market analysis.

Chapter 1. Global Clinical Trial Biorepository & Archiving Solutions Market Executive Summary 1.1. Global Clinical Trial Biorepository & Archiving Solutions Market Size & Forecast (2022-2032)

1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Service
- 1.3.2. By Product
- 1.3.3. By Phase
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Clinical Trial Biorepository & Archiving Solutions Market Definition and Research Assumptions 2.1. Research Objective

2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Clinical Trial Biorepository & Archiving Solutions Market Dynamics 3.1. Market Drivers

3.1.1. Growth in Clinical Trials Globally
3.1.2. Advancements in Biobanking Technologies
3.1.3. Increasing Investments in R&D

3.2. Market Challenges
- 3.2.1. High Infrastructure Costs
- 3.2.2. Stringent Regulatory Requirements
3.3. Market Opportunities
- 3.3.1. Expansion of Pharmaceutical Pipelines
- 3.3.2. Rise in Multi-Center Trials
- 3.3.3. Integration of Digital Technologies

Chapter 4. Global Clinical Trial Biorepository & Archiving Solutions Market Industry Analysis 4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis

4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Trial Biorepository & Archiving Solutions Market Size & Forecasts by Service 2022-2032 5.1. Segment Dashboard

5.2. Global Clinical Trial Biorepository & Archiving Solutions Market: Service Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Biorepository Services
- 5.2.2. Archiving Solution Services

Chapter 6. Global Clinical Trial Biorepository & Archiving Solutions Market Size & Forecasts by Product 2022-2032 6.1. Segment Dashboard

6.2. Global Clinical Trial Biorepository & Archiving Solutions Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Instruments
- 6.2.2. Consumables

Chapter 7. Global Clinical Trial Biorepository & Archiving Solutions Market Size & Forecasts by Phase 2022-2032 7.1. Segment Dashboard

7.2. Global Clinical Trial Biorepository & Archiving Solutions Market: Phase Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Preclinical
- 7.2.2. Phase I
- 7.2.3. Phase II
- 7.2.4. Phase III
- 7.2.5. Phase IV

Chapter 8. Global Clinical Trial Biorepository & Archiving Solutions Market Size & Forecasts by Region 2022-2032 8.1. North America Clinical Trial Biorepository & Archiving Solutions Market

8.1.1. U.S. Clinical Trial Biorepository & Archiving Solutions Market
- 8.1.1.1. Service Breakdown Size & Forecasts, 2022-2032
- 8.1.1.2. Product Breakdown Size & Forecasts, 2022-2032
8.1.2. Canada Clinical Trial Biorepository & Archiving Solutions Market

8.2. Europe Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.1. U.K. Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.2. Germany Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.3. France Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.4. Spain Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.5. Italy Clinical Trial Biorepository & Archiving Solutions Market
- 8.2.6. Rest of Europe Clinical Trial Biorepository & Archiving Solutions Market
8.3. Asia-Pacific Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.1. China Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.2. India Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.3. Japan Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.4. Australia Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.5. South Korea Clinical Trial Biorepository & Archiving Solutions Market
- 8.3.6. Rest of Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market
8.4. Latin America Clinical Trial Biorepository & Archiving Solutions Market
- 8.4.1. Brazil Clinical Trial Biorepository & Archiving Solutions Market
- 8.4.2. Mexico Clinical Trial Biorepository & Archiving Solutions Market
- 8.4.3. Rest of Latin America Clinical Trial Biorepository & Archiving Solutions Market
8.5. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market
- 8.5.1. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions Market
- 8.5.2. South Africa Clinical Trial Biorepository & Archiving Solutions Market
- 8.5.3. Rest of Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market

Chapter 9. Competitive Intelligence 9.1. Key Company SWOT Analysis

9.1.1. Thermo Fisher Scientific Inc.
9.1.2. Tecan Group Ltd.
9.1.3. BioLife Solutions, Inc.

9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Thermo Fisher Scientific Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Tecan Group Ltd.
- 9.3.3. BioLife Solutions, Inc.
- 9.3.4. Merck KGaA
- 9.3.5. Hamilton Company
- 9.3.6. Brooks Automation, Inc.
- 9.3.7. VWR International, LLC
- 9.3.8. LabVantage Solutions, Inc.
- 9.3.9. Cryoport, Inc.
- 9.3.10. Cell & Co Bioservices

Chapter 10. Research Process 10.1. Research Process

10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing

10.2. Research Attributes